No Data
No Data
Cantor Fitzgerald Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $107
Cantor Fitzgerald Remains a Buy on Axsome Therapeutics (AXSM)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
Needham Starts Axsome at Buy, Cites Revenue Growth Potential
Salmon Klein : are you in $Macrogenics (MGNX.US)$ ? tell me when good to jump in
MangoXXXX Salmon Klein : Now
Meticulous Trader Salmon Klein : Do your own research , I think hovering in bottom and buy signal from pattern about to begin , do not follow me blindly my
![grin 😁](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f601.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)
Salmon Klein Meticulous Trader : I am waiting to reach 14.8 or so, but I am busy working, if it reached the bottom and you are in...any good feedback is always very welcomed bro...just that so thanks
Meticulous Trader Salmon Klein : Double higher bottom in intra-day might not hit below 14ish or if so still chance for 2 more trading sideways days, I am almost 25% down ( reason holding beyond top) anyway![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)